LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

LifeMD, Inc.NASDAQ: LFMD

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue declines year over year

Q1 FY2026 revenue of $50.16M fell 23.6% year over year, behind the -6.2% change in trailing-twelve-month revenue. Sequentially, it rose 7.0% from the prior quarter. Over 3 fiscal years it compounded at +17.7% a year.

Context

  • Revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether revenue reaches the consensus estimate from 5 analysts of $191.9M (-1.1%) for the fiscal year ending Dec 2026, a step up from the -8.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$50.16M+7.0% QoQ
Last fiscal yearDec 2025
$194.06M-8.7% YoY
LTMMar 2026
$219.42M-6.2% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-23.6%-21.0%+2.7 pp
1 year-8.7%-1.1%+7.6 pp
3-year CAGR+17.7%+13.9%-3.8 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
194.06M USD
Year-over-year change
-8.7%
4-year CAGR
+20.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -6.2% is the lowest of 10, against a peer median of +11.7%.
  • Over three fiscal years its annual growth of +17.7% compares with a peer median of +8.4%.
LFMD Competitors
Revenue for LFMD and competitors
Company Period LTM YoY 3-year CAGR
HITIHigh Tide Inc.LTM Apr 2026CA$671.57M CAD+22.0%+18.5%
TBRGTruBridge, Inc.LTM Mar 2026$345.9M USD-0.5%+2.0%
CERSCerus CorporationLTM Mar 2026$222.79M USD+20.3%+8.4%
LFMDLifeMD, Inc.LTM Mar 2026$219.42M USD-6.2%+17.7%
SMTISanara MedTech Inc.LTM Mar 2026$107.51M USD+17.4%+31.0%
SGHTSight Sciences, Inc.LTM Mar 2026$79.55M USD+1.8%+2.7%
CVRXCVRx, Inc.LTM Mar 2026$59.07M USD+11.7%+36.1%
MASS908 Devices Inc.LTM Mar 2026$57.8M USD+2.2%+6.2%
TKNOAlpha Teknova, Inc.LTM Mar 2026$41.8M USD+9.3%-0.7%
SENSSenseonics Holdings, Inc.LTM Mar 2026$40.71M USD+71.9%+29.1%
Peer median (excluding LFMD) —+11.7%+8.4%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue92.88M119.03M152.55M212.45M194.06M
Cost of Revenue18M18.67M18.9M24.07M39.29M
Gross Profit74.88M100.37M133.65M188.39M154.76M
Gross Margin80.6%84.3%87.6%88.7%79.8%
Research & Development948.16K2.97M6.06M9.51M7.35M
Selling, General & Admin122.08M125.33M128.15M175.68M144.01M
Operating Expenses129.18M143.81M148.14M204.53M162.43M
Depreciation & Amortization355.87K1.09M6.6M9.49M7.31M
EBITDA(57.94M)(38.6M)(8.21M)(6.65M)(1.52M)
EBITDA Margin-62.4%-32.4%-5.4%-3.1%-0.8%
Operating Income(54.3M)(43.45M)(14.49M)(16.14M)(7.67M)
Operating Margin-58.5%-36.5%-9.5%-7.6%-4.0%
Interest Income00000
Interest Expense3.02M1.28M2.6M2.18M1.36M
Other Income / Expenses(7.02M)(1.21M)(2.92M)(2.18M)(2.52M)
Income Before Tax(61.32M)(44.66M)(17.41M)(18.33M)(10.19M)
Pre-Tax Margin-66.0%-37.5%-11.4%-8.6%-5.2%
Income Tax Expense7.7K360.7K428K402K45.72K
Net Income(60.9M)(45.54M)(20.6M)(18.88M)(7.11M)
Net Margin-65.6%-38.3%-13.5%-8.9%-3.7%
EPS (Basic)(2.27)(1.57)(0.70)(0.53)(0.23)
EPS (Diluted)(2.27)(1.57)(0.70)(0.53)(0.23)
Weighted Avg Shares27.01M30.98M33.91M41.2M45.13M
Weighted Avg Shares (Diluted)27.01M30.98M33.91M41.2M45.13M

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.